Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Study of an intratumoral delivery of NZ-DTX Depot in men with localized prostate cancer who are scheduled for prostatectomy

Next Previous
X
Search
Trial Profile

Study of an intratumoral delivery of NZ-DTX Depot in men with localized prostate cancer who are scheduled for prostatectomy

Status: Planning
Phase of Trial: Phase I

Latest Information Update: 28 Feb 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Docetaxel (Primary)
  • Indications Prostate cancer
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors LIDDS

    • Most Recent Events

    • 22 Feb 2024 According to a LIDDS media release, this study was never started due to the cost-cutting measures initiated in June.
    • 19 Apr 2021 New trial record
    • 16 Apr 2021 According to a LIDDS media release,the application for a new clinical study at Uppsala University Hospital has been submitted. Also, the study is planned to start in mid of this year having Dr. Michael Haggman (Associate Professor at the Department of Surgical Sciences in Urology) as a principal investigator.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top